These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
903 related items for PubMed ID: 7599335
1. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. Dajani EZ, Agrawal NM. J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335 [Abstract] [Full Text] [Related]
2. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. Agrawal NM, Dajani EZ. J Assoc Acad Minor Phys; 1992 Mar; 3(4):142-8. PubMed ID: 1392409 [Abstract] [Full Text] [Related]
3. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM. J Clin Gastroenterol; 1990 Mar; 12 Suppl 2():S13-20. PubMed ID: 1978842 [Abstract] [Full Text] [Related]
4. Prostaglandins: an overview of the worldwide clinical experience. Dajani EZ, Wilson DE, Agrawal NM. J Assoc Acad Minor Phys; 1991 Mar; 2(1):23, 27-35. PubMed ID: 1811816 [Abstract] [Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [Abstract] [Full Text] [Related]
9. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. Agrawal NM, Dajani EZ. J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964 [Abstract] [Full Text] [Related]
10. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Agrawal NM, Dajani EZ. Int J Clin Pharmacol Res; 1989 Feb; 9(6):347-57. PubMed ID: 2576801 [Abstract] [Full Text] [Related]
11. [Prevention of NSAID induced gastroduodenal ulcers]. Hansen JM, Bytzer P. Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151 [Abstract] [Full Text] [Related]
12. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. Miller DR. Clin Pharm; 1992 Aug 29; 11(8):690-704. PubMed ID: 1511542 [Abstract] [Full Text] [Related]
13. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM. Best Pract Res Clin Gastroenterol; 2001 Oct 29; 15(5):755-73. PubMed ID: 11566039 [Abstract] [Full Text] [Related]
14. [Present position in the prevention and therapy of NSAID-induced ulcers]. Lehmann FS, Beglinger C. Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910 [Abstract] [Full Text] [Related]
15. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. J Rheumatol; 2002 Mar 27; 29(3):467-73. PubMed ID: 11908558 [Abstract] [Full Text] [Related]
16. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment. Zfass AM, McHenry L, Sanyal AJ. Gastroenterologist; 1993 Jun 27; 1(2):165-9. PubMed ID: 8049889 [Abstract] [Full Text] [Related]
17. Treatment and prevention of NSAID induced gastroduodenal mucosal damage. Agrawal NM, Saggioro A. J Rheumatol Suppl; 1991 Mar 27; 28():15-8. PubMed ID: 1674754 [Abstract] [Full Text] [Related]
18. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dajani EZ, Agrawal NM. Dig Dis; 1995 Jan 27; 13 Suppl 1():48-61. PubMed ID: 7697902 [Abstract] [Full Text] [Related]
19. Role of acid suppressants in prophylaxis of NSAID damage. Chan FK, Sung JJ. Best Pract Res Clin Gastroenterol; 2001 Jun 27; 15(3):433-45. PubMed ID: 11403537 [Abstract] [Full Text] [Related]
20. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Laine L. Rev Gastroenterol Disord; 2003 Jun 27; 3 Suppl 4():S30-9. PubMed ID: 14671512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]